These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32193666)

  • 1. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.
    Regier PS; Kampman KM; Childress AR
    Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory toxicities from stimulant use.
    Albertson TE; Walby WF
    Clin Rev Allergy Immunol; 1997; 15(3):221-41. PubMed ID: 9358986
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychostimulant treatment of cocaine dependence.
    Mariani JJ; Levin FR
    Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addictiveness of central stimulants.
    Dackis CA; Gold MS
    Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming cocaine or stimulant addiction. Medications offer modest help; vaccines are in development.
    Harv Ment Health Lett; 2009 Mar; 25(9):6-7. PubMed ID: 19368038
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of stimulant drugs in a community sample of drug users.
    Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
    Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.
    Reske M; Eidt CA; Delis DC; Paulus MP
    Biol Psychiatry; 2010 Oct; 68(8):762-9. PubMed ID: 20605137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
    Ciccarone D
    Prim Care; 2011 Mar; 38(1):41-58. PubMed ID: 21356420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of stimulant dependence.
    Schuckit MA
    Addiction; 1994 Nov; 89(11):1559-63. PubMed ID: 7841871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of stimulant misuse.
    Kaplan CD; Husch JA; Bieleman B
    Addiction; 1994 Nov; 89(11):1517-21. PubMed ID: 7841865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responding to global stimulant use: challenges and opportunities.
    Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R
    Lancet; 2019 Nov; 394(10209):1652-1667. PubMed ID: 31668409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.
    Stoops WW; Rush CR
    Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
    Rothman RB; Blough BE; Baumann MH
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):458-74. PubMed ID: 19086767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant Drugs of Abuse and Cardiac Arrhythmias.
    Dominic P; Ahmad J; Awwab H; Bhuiyan MS; Kevil CG; Goeders NE; Murnane KS; Patterson JC; Sandau KE; Gopinathannair R; Olshansky B
    Circ Arrhythm Electrophysiol; 2022 Jan; 15(1):e010273. PubMed ID: 34961335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication development for addictive disorders: the state of the science.
    Vocci FJ; Acri J; Elkashef A
    Am J Psychiatry; 2005 Aug; 162(8):1432-40. PubMed ID: 16055764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of central nervous system stimulants.
    Holman RB
    Addiction; 1994 Nov; 89(11):1435-41. PubMed ID: 7841853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
    Howell LL; Negus SS
    Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine and stimulant addiction.
    Sofuoglu M; Sewell RA
    Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.